InterSystems Wins Frost & Sullivan 2012 European Company of the Year Award in Integrated Connected Health Technologies

InterSystemsInterSystems Corporation, a global leader in software for connected care, has been awarded the Frost & Sullivan 2012 European Company of the Year Award in Integrated Connected Health Technologies. Frost & Sullivan cited InterSystems for both its product innovation and its ability to deliver excellent customer value. In particular Frost & Sullivan’s analysts praised the InterSystems HealthShare® strategic informatics platform, which it described as "a one-stop solution that enables users to capture, share and understand and act on all their data, both structured and unstructured".

InterSystems was benchmarked against its competitors in five key areas:

  • Degree of innovation with products and technologies
  • Leadership in customer value
  • Growth strategy excellence
  • Growth implementation excellence
  • Leadership in market penetration

"The importance of integrated, connected care cannot be overstated as a key requirement for the next generation of healthcare informatics. With the ability to continuously derive value from their information and make it actionable at the point of care, health organisations can achieve the breakthrough transformation they need to address the challenges of managing costs while improving the quality of care," said Dominick Bizzarro, Global Business Manager, InterSystems HealthShare.

InterSystems HealthShare is a strategic healthcare informatics platform for hospitals, integrated delivery networks, and regional and national health information exchanges.

It is built on the InterSystems Caché® database and InterSystems Ensemble® integration platform. InterSystems DeepSee provides embedded real-time business intelligence capabilities, and InterSystems iKnow provides the ability to discover concepts and relationships within unstructured data.

The judges highlighted InterSystems' successful nationwide projects in countries including Sweden, Denmark, the Netherlands, and Scotland. They also cited InterSystems' growing reputation as a creative technology partner focused on advancing its implementation technology and post-implementation support to ensure customers achieve and exceed the expected value.

"Frost & Sullivan believes that InterSystems’ business strategy is customer-focused, and this has helped it to provide technologies that are widely used in the healthcare space. Its applications embed interoperability, analytics and other key components, which help its customers gain a competitive edge. All of these factors help InterSystems emerge as the worthy recipient of the 2012 Frost & Sullivan Company of the Year Award in the European Integrated Connected Health Technologies Market," said Divyaa Ravishankar, Senior Research Analyst, Healthcare and Lifescience IT, Frost & Sullivan.

"This award is excellent recognition for the work we are doing in Europe," said Jonathan Selby, UK & Ireland Country Manager at InterSystems. "We are continuing to grow our footprint in the European market by delivering outstanding technical innovation, real value for our partners and customers, and a connected care strategy that is ultimately focused on improving patient outcomes."

Related news articles:

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

About InterSystems
InterSystems Corporation is a global leader in software for connected care, with headquarters in Cambridge, Massachusetts, and offices in 25 countries. InterSystems CACHÉ® is the world's most widely used database system in clinical applications. InterSystems Ensemble® is a platform for rapid integration and the development of connectable applications. InterSystems HealthShare™ is a strategic healthcare informatics platform for information exchange and analytics within a hospital network, and across a community, region or nation. InterSystems' products are used by thousands of hospitals and laboratories worldwide, including all of the top ten hospitals on the Honor Roll of America's Best Hospitals as rated by U.S. News and World Report.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...